Literature DB >> 26567794

Intravitreal Ciliary Neurotrophic Factor Transiently Improves Cone-Mediated Function in a CNGB3-/- Mouse Model of Achromatopsia.

Dario Marangoni1, Camasamudram Vijayasarathy2, Ronald A Bush2, Lisa L Wei3, Rong Wen4, Paul A Sieving5.   

Abstract

PURPOSE: Ciliary neurotrophic factor (CNTF) was recently shown to augment cone function in CNGB3 mutant achromat dogs. However, testing CNTF-releasing implant in human CNGB3 achromats failed to show benefit. We evaluated the effects of CNTF protein on the retinal function in an additional achromatopsia model, the CNGB3-/- mouse.
METHODS: Fifty-nine CNGB3-/- mice (postnatal day [PD] ± SD = 30 ± 7) received a unilateral intravitreal injection of 1 or 2 μg CNTF protein, and 15 wild-type (WT) mice (PD = 34 ± 3) received 1 μg CNTF. Retinal function was evaluated by flash ERG and photopic flicker ERG (fERG) at 7 and 14 days after treatment.
RESULTS: Seven days post CNTF, the photopic b-wave Vmax was significantly increased in CNGB3-/- mice (P < 0.01), whereas it was reduced in WT mice (P < 0.05). Ciliary neurotrophic factor significantly increased the amplitude of photopic fERG and the photopic oscillatory potentials (OPs) in CNGB3-/- mice. Ciliary neurotrophic factor did not alter the scotopic a-wave in either CNGB3-/- or WT mice, but it increased the scotopic b-wave k (P < 0.01) in CNGB3-/- mice, indicating diminished scotopic sensitivity, and reduced the scotopic b-wave Vmax in WT mice (P < 0.05). No difference was found in ERG parameters between 1 or 2 μg CNTF. Fourteen days after CNTF injection the ERG changes in CNGB3-/- mice were lost.
CONCLUSIONS: Intravitreal bolus CNTF protein caused a small and transient improvement of cone-mediated function in CNGB3-/- mice, whereas it reduced rod-mediated function. The increase in photopic OPs and the lack of changes in scotopic a-wave suggest a CNTF effect on the inner retina.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26567794      PMCID: PMC4627357          DOI: 10.1167/iovs.15-16866

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  43 in total

1.  Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats.

Authors:  T Sugawara; P A Sieving; R A Bush
Journal:  Exp Eye Res       Date:  2000-05       Impact factor: 3.467

2.  Primate photopic sine-wave flicker ERG: vector modeling analysis of component origins using glutamate analogs.

Authors:  M Kondo; P A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-01       Impact factor: 4.799

3.  Molecular cloning and functional characterization of a new modulatory cyclic nucleotide-gated channel subunit from mouse retina.

Authors:  A Gerstner; X Zong; F Hofmann; M Biel
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

4.  Gene expression of neurotrophins and their high-affinity Trk receptors in cultured human Müller cells.

Authors:  Hidehiro Oku; Tsunehiko Ikeda; Youichi Honma; Chie Sotozono; Kohji Nishida; Yo Nakamura; Teruyo Kida; Shigeru Kinoshita
Journal:  Ophthalmic Res       Date:  2002 Jan-Feb       Impact factor: 2.892

5.  The scotopic threshold response of the dark-adapted electroretinogram of the mouse.

Authors:  Shannon M Saszik; John G Robson; Laura J Frishman
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

6.  Pharmacological analysis of the rat cone electroretinogram.

Authors:  Li Xu; Sherry L Ball; Kenneth R Alexander; Neal S Peachey
Journal:  Vis Neurosci       Date:  2003 May-Jun       Impact factor: 3.241

Review 7.  Cyclic nucleotide-gated ion channels.

Authors:  U Benjamin Kaupp; Reinhard Seifert
Journal:  Physiol Rev       Date:  2002-07       Impact factor: 37.312

8.  CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.

Authors:  Daniel M Lipinski; Alun R Barnard; Mandeep S Singh; Chris Martin; Edward J Lee; Wayne I L Davies; Robert E MacLaren
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

9.  Rescue of retinal function by BDNF in a mouse model of glaucoma.

Authors:  Luciano Domenici; Nicola Origlia; Benedetto Falsini; Elisa Cerri; Davide Barloscio; Carlotta Fabiani; Marco Sansò; Luca Giovannini
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

View more
  4 in total

1.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

Review 2.  Advances in Gene Therapy for Diseases of the Eye.

Authors:  Lolita Petit; Hemant Khanna; Claudio Punzo
Journal:  Hum Gene Ther       Date:  2016-06-13       Impact factor: 5.695

3.  Trans-ocular Electric Current In Vivo Enhances AAV-Mediated Retinal Gene Transduction after Intravitreal Vector Administration.

Authors:  Hongman Song; Ronald A Bush; Yong Zeng; Haohua Qian; Zhijian Wu; Paul A Sieving
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-21       Impact factor: 6.698

4.  Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration.

Authors:  Xufeng Dai; Hua Zhang; Juanjuan Han; Ying He; Yangyang Zhang; Yan Qi; Ji-Jing Pang
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.